Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Gen-Probe
    Registered Vendor
    • Apr 2011
    • 1

    #1

    Director, Bioinformatics at Gen-Probe

    “The Power to Look Deeper”Gen-Probe Incorporated (NASDAQ:GPRO) is a global leader in the development, manufacture and marketing of molecular diagnostics products and services that are used to diagnose human diseases, screen donated human blood, ensure transplant compatibility, and aid biomedical research. Gen-Probe has nearly three decades of molecular diagnostics expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing molecular assays and systems that help safeguard the blood supply. Headquartered in San Diego, CA, and with offices in Stamford, CT, Waukesha, WI, the United Kingdom, Germany, France and Belgium, Gen-Probe employs over 1300 people around the world.

    “The Power to Shape Your Future”We are seeking a Director, Bioinformatics to be heavily involved with defining our bioinformatics strategy for analysis of next-generation sequencing data for the clinical diagnostics lab, from raw data to clinically-actionable results. Will oversee the design, development, and implementation of innovative bioinformatics workflows and evaluate and provide recommendations on 3rd party bioinformatics tools, while providing technical leadership and supervision to the bioinformatics team.

    DESCRIPTION OF POSITION RESPONSIBILITIES:
    •Participates as key member of a cross-functional team responsible for defining the overall development and commercial strategy for novel sample-to-answer sequencing-based clinical diagnostics.
    •Performs statistical modeling to help define specifications for sequencing data output to meet clinical performance requirements.
    •Works with our Development group on integration of bioinformatics pipeline with instrumentation software, including interface to Healthcare Information Systems and Electronic Medical Records.
    •Maintains expertise in state-of-the-art bioinformatics methods; works with regulatory bodies and standards organizations to help define standards for NGS data in the clinical lab environment.

    EDUCATION AND EXPERIENCE REQUIREMENTS:
    •Master’s Degree or Ph.D in Bioinformatics, or closely related field (Mathematics, Computer Science, Physics, Engineering) and 10+ years experience in the field of bioinformatics including an established track record in next-generation sequencing data analysis and extensive experience supervising and directing bioinformatics projects.
    •Proven experience working with large genomic datasets including integration with public and private databases.
    •Hands-on expertise with open source and 3rd party bioinformatics tools and applications for analysis of next gen sequencing data. Experience with R, C/C++, Java, SQL, Perl, and Python. Proficient in Unix/Linux.
    •Strong foundation in molecular biology, molecular genetics, biostatistics.

    Gen-Probe offers a dynamic and innovative work environment along with excellent benefits that include sponsored medical/dental/vision benefits, stock options (NASDAQ:GPRO), bonus potential, 401(k) w/company match, paid vacation/sick time /holidays, assistance with continuing education, on-site fitness center, and our own Waterfall Café.

    We invite you to view our Career Video!
    http://www.view-career-video.com/videos/genprobe/

    Apply directly at:

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...